Authors: ROTH MD GITLITZ BJ KIERTSCHER SM PARK AN NG M MENDENHALL M MOLDAWER N FIGLIN RA

Citation: Md. Roth et al., COMBINATION IMMUNOTHERAPY WITH RGM-CSF AND RIL-4 IN PATIENTS WITH CANCER - EFFECTS ON ANTIGEN-PRESENTING CELLS (APC) AND APC ACTIVITY, The FASEB journal, 12(5), 1998, pp. 5144-5144

Authors: HINKEL A GITLITZ BJ KABOO R MULDERS P DEKEMION JB FIGLIN RA BELLDEGRUN A

Citation: A. Hinkel et al., DENDRITIC CELL (DC) THERAPY FOR METASTATIC RENAL-CELL CANCER (MRCC) -FROM BASIC RESEARCH TO PHASE-I CLINICAL-TRIAL, The Journal of urology, 159(5), 1998, pp. 564-564

Authors: HINKEL A GITLITZ BJ KABOO R TSO CL DEKERNION JB FIGLIN RA BELLDEGRUN A

Citation: A. Hinkel et al., A NOVEL TECHNIQUE FOR GENERATING TUMOR LYSATE (TULY) LOADED DENDRITICCELLS (DC) FOR USE IN TUMOR VACCINE ADOPTIVE IMMUNOTHERAPY OR RENAL-CELL CANCER/, The Journal of urology, 159(5), 1998, pp. 652-652

Authors: FIGLIN RA GITLITZ BJ BELLDEGRUN A

Citation: Ra. Figlin et al., IMMUNOLOGICAL APPROACHES TO THE TREATMENT OF CANCER, Cancer investigation, 13(3), 1995, pp. 339-340